-
Drug Use Evaluation of Tenofovir/Lamivudine/Dolutegravir (TLD) Fixed-Dose Combination for Initiation and Transition Among HIV-Infected Individuals Attending Lumame Primary Hospital, North West Ethiopia
18 Apr 2024 07:34 GMT
… dangerous side effects, drug interactions, and drug resistance.12 On … and appropriate use of pharmaceuticals, medical procedures, and new research … with co-infection with hepatitis B or C or … . Dolutegravir and lamivudine combination for the treatment of HIV-1 …
-
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care
16 Apr 2024 07:27 GMT
… UK; 5Department of Medicine, AIDS Healthcare Foundation … warning stating that additional treatment or … Drug–drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment … Drug Administration (FDA). FDA approves first two-drug complete …
-
FDA Approves Dovato for Teens Living With HIV
15 Apr 2024 13:47 GMT
… Drug Administration approved ViiV Healthcare’s Dovato (dolutegravir/lamivudine) pill … Phase IIIb DANCE trial (NCT03682848), which … , as well as trials in adults, including … hepatitis flare-ups can occur when a person taking lamivudine stops treatment …
-
FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection
08 Apr 2024 21:00 GMT
… FDA has approved dolutegravir/lamivudine (Dovato; ViiV Healthcare) for the treatment … day. The 2 medicines inhibit the viral … open-label phase 3b trial, DANCE (NCT03682848), which … elevated serum liver biochemistries, hepatitis, and acute liver failure), …
-
More treatments available to 30,000 New Zealanders
14 Apr 2024 05:53 GMT
… supplier GlaxoSmithKline (GSK) for these medicines. By finding savings on some … .
Funding a treatment for human immunodeficiency virus (HIV), dolutegravir with lamivudine (branded …
-
Week in review: A new dermatology case study, and a new treatment for severe asthma
12 Apr 2024 23:33 GMT
… with no significant past medical history returns from hiking … full FDA approval details.
3.) FDA approves dolutegravir/lamivudine to … no antiretroviral (ARV) treatment history or to replace … components of [dolutegravir/lamivudine]," ViiV stated.
…
-
Pharmac inks deal with GlaxoSmithKline for new cancer, HIV and COPD drugs
12 Apr 2024 03:20 GMT
… medicines under a deal between Pharmac and pharmaceutical giant GlaxoSmithKline.
The government drug …
The decision included:
maintenance treatment for ovarian cancer, niraparib … a treatment for human immunodeficiency virus (HIV), dolutegravir with lamivudine …
-
Pharmac funds wider range of medication, thought to help 30,000 people
12 Apr 2024 00:42 GMT
… Pharmac increased the medication it continues to fund, the drug-buying agency … prescribers to give this treatment as needed."
Pills (file photo) (Source … HIV, the anti-viral medication dolutegravir with lamivudine (branded as Dovato) will …
-
FDA Approves HIV Therapy for Adolescents
08 Apr 2024 21:39 GMT
… an oral, two-drug, single-tablet regimen … medicines—an important consideration for young people who will require lifelong treatment … lamivudine, a nucleoside reverse transcriptase inhibitor, potentially simplifying treatment … 48.
The FDA approval coincides with …
-
FDA approves dolutegravir/lamivudine to treat HIV infection in adolescents
08 Apr 2024 21:23 GMT
… been approved by the FDA for the treatment of HIV-1 … the approved population. The trial enrolled 32 participants across 9 … in adult trials.
The once-daily, oral, 2-drug, single-tablet … WITH HEPATITIS B VIRUS (HBV) AND HIV-1: EMERGENCE OF LAMIVUDINE-RESISTANT …